Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb 1;110(2):485-487.
doi: 10.3324/haematol.2024.285329.

Unraveling the germline inheritance of the JAK2 F556V gene mutation in familial thrombocythemia: a comprehensive analysis of 11 family members and potential implications for surveillance

Affiliations

Unraveling the germline inheritance of the JAK2 F556V gene mutation in familial thrombocythemia: a comprehensive analysis of 11 family members and potential implications for surveillance

Manja Meggendorfer et al. Haematologica. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Pedigree of the initial patient. Initial patient marked in light blue. Red sex symbols represent patients with thrombocytosis. Thrombocytosis was based on platelet counts exceeding 400x109/L following standard diagnostics. Platelet counts are given. +/- indicate the JAK2 F556V alteration tested with either detection (+) or no detection (-). The orange background of JAK2 mutation status (+/-) shows the germline confirmation by detection in buccal swap and nail clippings. Light gray boxes show married-in family members. The year of birth of the patient is indicated where known.

Similar articles

Cited by

References

    1. Teofili L, Larocca LM. Advances in understanding the pathogenesis of familial thrombocythaemia. Br J Haematol. 2011;152(6): 701-712. - PubMed
    1. Baxter EJ, Scott LM, Campbell PJ, et al. . Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet. 2005;365(9464):1054-1061. - PubMed
    1. Kralovics R, Passamonti F, Buser AS, et al. . A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med. 2005;352(17):1779-1790. - PubMed
    1. Levine RL, Wadleigh M, Cools J, et al. . Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell. 2005;7(4):387-397. - PubMed
    1. Han EY, Catherwood M, McMullin MF. Hereditary thrombocytosis: the genetic landscape. Br J Haematol. 2021;194(6):1098-1105. - PubMed

LinkOut - more resources